FDA unveils multilingual health fraud protection initiative for consumers
By: Jonca Bull, M.D., and Jason Humbert, R.N. Consumers are constantly bombarded by advertisements for fraudulent medical treatments and cures — dangerous scams that often target the most vulnerable...
View ArticleGE Healthcare looks to cut costs, boost margins
GE Healthcare (NYSE:GE) is looking to reverse a slump in operating margins with a 2% increase this year, CEO John Flannery said last week. The goal is 18% by the end of 2018, Flannery said during a GE...
View ArticleIntuitive Surgical wins FDA nod for new EndoWrist stapler
Intuitive Surgical (NSDQ:ISRG) said today that the FDA cleared a new EndoWrist stapler for its next-generation da Vinci Xi root-assisted surgery device. The 510(k) clearance for the EndoWrist 30 device...
View ArticleArterys raises $12m Series A round from MR-based vascular imaging
Arterys said today that it raised a $12 million Series A round for the MR-based vascular imaging system it’s developing. The San Francisco-based company said its system uses data from a 10-minute MRI...
View ArticleMonteris Medical expands to new HQ in Minn.
Monteris Medical said today it is opening a new facility that will act as its headquarters in Plymouth, Minn. on Wednesday this week. Plymouth Mayor Kelli Slavik will host a ribbon cutting event for...
View ArticleCEO Shortall, COO Mojdeh out as Unilife retools | Personnel Moves
Unilife (NSDQ:UNIS) said today that chairman & CEO Alan Shortall and president & COO Ramin Mojdeh are out, effective immediately, as it reorganizes to focus on its revenue-generating programs...
View ArticleNext-gen blood collection device maker Magnolia Medical raises $1.4m
Seattle-based Magnolia Medical Technologies brought in $1.4 million in a new round of debt financing and looks to bring in another $1.6 million before closing the round, according to an SEC filing...
View ArticleOrthofix puts $1.3m into Musculoskeletal Transplant Foundation deal
Orthofix (NSDQ:OFIX) said last week it is investing $1.3 million into the Musculoskeletal Transplant Foundation through a collaborative agreement to support the procurement and installation of...
View ArticleHitachi, Redlen ink development deal for next-gen CT component
Hitachi (NYSE:HIT) and Redlen Technologies said they inked a deal to co-develop a component used in photon-counting computed tomography devices. The Japanese conglomerate’s Hitachi Medical subsidiary...
View ArticleTitan Medical taps IR firm
Titan Medical (CVE:TMD) said last week that it hired an outside firm, EVC Group, to create and execute an investor relations program in Canada and the U.S. The Toronto-based robot-assisted surgery...
View ArticleExalenz & ALF Study Group ink deal for BreathID acute liver failure study
Exalenz Biosciences said today it inked a collaborative deal with the Acute Liver Failure Study Group to support a study of the BreathID methacetin breath test’s ability to predict outcomes in patients...
View ArticleCoapt licenses implantable Purdue tech for prosthetics
Coapt said it licensed implantable technology from the Purdue Research Foundation for implantable electrodes used to amplify the signal between muscles and prosthetic limbs. Chicago-based Coapt said it...
View ArticleSuperSonic Imagine inks distro deal with Sandhill Scientific, releases 2015...
SuperSonic Imagine said today it inked a U.S. distribution deal with Sandhill Scientific to distribute its Aixplorer ShearWave Elastography-equipped ultrasound system designed to assess liver disease,...
View ArticleMassDevice.com +3 | The top 3 medtech stories for March 14, 2016
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticleBiotronik’s BioMonitor 2 hits U.K., Ireland
Biotronik said today it launched its BioMonitor 2 subcutaneous insertable cardiac monitor in the U.K. and Ireland. The BioMonitor 2 device is designed for remote monitoring of patients with atrial...
View ArticleJohn Grisham book turns spotlight on futuristic cancer treatment
(Reuters) – A new book by bestselling author John Grisham is giving new impetus to a handful of companies striving to develop what they say could be a trailblazing treatment for cancer and Alzheimer’s...
View ArticleConcussions, TBI, the NFL and science
by Lisa Harvey With Super Bowl 50 behind us, it’s a good time to look back at the concerns revolving around concussions and contact sports. The NFL has introduced concussion protocols and invested in...
View ArticleEnlabel Global Services Gold Sponsor of 4th Semi-annual Medical Device &...
enLabel Global Services is the second-time Gold Sponsor of the 4th Semi-Annual Medical Device and Diagnostics Labeling Conference, hosted by Q1 Productions, on April 25-26, in Arlington, Virginia. The...
View ArticleThree bills affecting FDA medical device oversight advance in US senate
By Stewart Eisenhart, Emergo Group Proposed legislation targeting the Food and Drug Administration’s medical device premarket review processes as well as the scope of the agency’s oversight over...
View ArticleJohnson & Johnson bails on Sedasys anesthesia device
Johnson & Johnson (NYSE:JNJ) reportedly confirmed last week that it’s discontinuing its Sedasys computerized anesthesia system, 3 years after a hard-won pre-market approval from the FDA. The...
View Article